SLC2A1 expression is negatively correlated with CD8+ T cells in 12 types of cancers (STES, TGCT, ESCA, LUSC, SKCM, LUAD, BLCA, HNSC, CESC, LAMLC, THYM, and GBM), but positively with CD8+ T cells in 5 types of cancers (PRAD, KIPAN, KIRP, CHOL, and LIHC) (Figure 13A). The gene discussed is CD8A; the disease is cancer.